Found 6 matching trials
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer PHASE1 The aim of this study is to investigate safety and diagnostic performance o...
Show More Location
Krankenhaus der Barmherzigen Schwestern
Learn More & Join Trial
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer PHASE2 Prostate cancer (PC) remains the most-common non-cutaneous cancer diagnosed...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers PHASE1 Visual assessment of diagnostic PET/CT (positron emission tomography/comput...
Show More Location
Multiple Locations
Learn More & Join Trial
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer PHASE2 This clinical trial studies the use of gallium-68 (68Ga)-DOTA-Bombesin as t...
Show More Location
Stanford University Hospitals and Clinics
Learn More & Join Trial
PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study PHASE2 The overall goal is to provide an innovative approach to restage patients w...
Show More Location
IRCCS Ospedale San Raffaele
Learn More & Join Trial
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer PHASE2 This phase II trial studies how well gallium Ga 68-labeled gastrin-releasin...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial